| __timestamp | Gilead Sciences, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 55402000 |
| Thursday, January 1, 2015 | 28633000000 | 66107000 |
| Friday, January 1, 2016 | 26129000000 | 103402000 |
| Sunday, January 1, 2017 | 21736000000 | 135736000 |
| Monday, January 1, 2018 | 17274000000 | 245116000 |
| Tuesday, January 1, 2019 | 17774000000 | 108935000 |
| Wednesday, January 1, 2020 | 20117000000 | 156000000 |
| Friday, January 1, 2021 | 20704000000 | 214957000 |
| Saturday, January 1, 2022 | 21624000000 | 143418000 |
| Sunday, January 1, 2023 | 20618000000 | 96265000 |
| Monday, January 1, 2024 | 78200000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, Gilead Sciences, Inc. and Ligand Pharmaceuticals Incorporated have showcased contrasting financial trajectories over the past decade. From 2014 to 2023, Gilead Sciences consistently reported a robust gross profit, peaking in 2015 with a 36% increase from the previous year. However, a gradual decline followed, with a notable dip in 2018, marking a 40% decrease from its peak.
Conversely, Ligand Pharmaceuticals, while operating on a smaller scale, demonstrated a remarkable growth trajectory. From a modest start in 2014, Ligand's gross profit surged by over 340% by 2018, highlighting its strategic advancements in the biotech sector.
This analysis underscores the dynamic nature of the biotech industry, where strategic innovation and market adaptation play pivotal roles in financial performance.
Gross Profit Trends Compared: Novo Nordisk A/S vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Johnson & Johnson vs Gilead Sciences, Inc.
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. and Zoetis Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Gross Profit Comparison: Gilead Sciences, Inc. and Exelixis, Inc. Trends
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Gross Profit Trends Compared: Gilead Sciences, Inc. vs Perrigo Company plc
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Alkermes plc vs Ligand Pharmaceuticals Incorporated
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.